Enovix (ENVX) to Release Earnings on Wednesday

Enovix (NASDAQ:ENVX) is expected to be releasing its Q4 2025 results before the market opens on Wednesday, February 18th. Analysts expect Enovix to post earnings of ($0.17) per share for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 19, 2026 at 4:00 PM ET.

Enovix Price Performance

Enovix stock opened at $6.28 on Wednesday. Enovix has a 1 year low of $5.27 and a 1 year high of $16.49. The company has a debt-to-equity ratio of 1.74, a quick ratio of 9.47 and a current ratio of 9.72. The firm has a 50 day moving average price of $7.74 and a 200 day moving average price of $9.42. The company has a market cap of $1.36 billion, a price-to-earnings ratio of -7.75 and a beta of 2.13.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on ENVX. Canaccord Genuity Group lowered their price objective on shares of Enovix from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Thursday, November 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Enovix in a research report on Monday, December 29th. JPMorgan Chase & Co. cut their price objective on Enovix from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Wednesday, November 12th. Cantor Fitzgerald decreased their target price on Enovix from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, November 6th. Finally, Northland Securities set a $16.00 target price on shares of Enovix in a research report on Monday, November 17th. Five research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $17.50.

Hedge Funds Weigh In On Enovix

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Private Advisor Group LLC increased its position in shares of Enovix by 2.7% during the third quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock worth $464,000 after acquiring an additional 1,242 shares during the last quarter. Parallel Advisors LLC increased its holdings in Enovix by 51.9% during the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after purchasing an additional 1,342 shares during the last quarter. Equitable Holdings Inc. raised its position in shares of Enovix by 10.9% in the 3rd quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock valued at $137,000 after purchasing an additional 1,342 shares in the last quarter. Mariner LLC raised its position in shares of Enovix by 3.4% in the 3rd quarter. Mariner LLC now owns 58,343 shares of the company’s stock valued at $582,000 after purchasing an additional 1,921 shares in the last quarter. Finally, Creative Planning boosted its stake in shares of Enovix by 5.8% during the 3rd quarter. Creative Planning now owns 36,483 shares of the company’s stock valued at $364,000 after buying an additional 2,006 shares during the last quarter. 50.92% of the stock is owned by hedge funds and other institutional investors.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.